Arama Sonuçları Safety. - Daraltılmış: Drug development.SirsiDynix Enterprisehttps://katalog.hacettepe.edu.tr/client/tr_TR/default_tr/default_tr/qu$003dSafety.$0026qf$003dSUBJECT$002509Subject$002509Drug$002bdevelopment.$002509Drug$002bdevelopment.$0026ps$003d300?2026-02-28T12:23:19ZTOXICOLOGIC PATHOLOGY nonclinical safety assessment.ent://SD_ILS/0/SD_ILS:5763182026-02-28T12:23:19Z2026-02-28T12:23:19ZYer Numarası RM301.25<br/>Elektronik Erişim Taylor & Francis <a href="https://www.taylorfrancis.com/books/9781003312048">https://www.taylorfrancis.com/books/9781003312048</a>
OCLC metadata license agreement <a href="http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf">http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Safety pharmacology in pharmaceutical development : approval and post marketing surveillanceent://SD_ILS/0/SD_ILS:5467782026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Gad, Shayne C., 1948, author. Gad, Shayne C., 1948- Safety pharmacology in pharmaceutical development and approval.<br/>Yer Numarası RM301.25 .G33 2012<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781439845684">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>Drug development principles, methodology and emerging challengesent://SD_ILS/0/SD_ILS:2810632026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Rossi, Marco. Bertone, Santina.<br/>Yer Numarası ONLINE<br/>Elektronik Erişim EBSCOhost <a href="http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=564963">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=564963</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Chemistry and pharmacology of drug discoveryent://SD_ILS/0/SD_ILS:5993492026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Li, Jie Jack, editor.<br/>Yer Numarası RM301.25 .C44 2025<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9781394225156">https://onlinelibrary.wiley.com/doi/book/10.1002/9781394225156</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Toxicologic pathology : a primerent://SD_ILS/0/SD_ILS:5884052026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Sahota, Pritam S., editor. Spaet, Robert H., editor. Wojcinski, Zbigniew W., editor.<br/>Yer Numarası RA1211<br/>Elektronik Erişim Taylor & Francis <a href="https://www.taylorfrancis.com/books/9780429354861">https://www.taylorfrancis.com/books/9780429354861</a>
OCLC metadata license agreement <a href="http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf">http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Supply chain planning for clinical trials : a practical guideent://SD_ILS/0/SD_ILS:5992752026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Mills, Ryan, 1982- author.<br/>Yer Numarası RM301.27 .M55 2024<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9781394179589">https://onlinelibrary.wiley.com/doi/book/10.1002/9781394179589</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Artificial intelligence and machine learning in drug design and developmentent://SD_ILS/0/SD_ILS:5992332026-02-28T12:23:19Z2026-02-28T12:23:19ZYer Numarası RM301.25 .A78 2024<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9781394234196">https://onlinelibrary.wiley.com/doi/book/10.1002/9781394234196</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Pharmaceutical Calibration, Validation and Qualification: A Comprehensive Approachent://SD_ILS/0/SD_ILS:5271512026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Shukla, Shiv Shankar. author. Pandey, Ravindra Kumar. author. Gidwani, Beena. author. Kalyani, Gunjan. author. SpringerLink (Online service)<br/>Yer Numarası ONLINE<br/>Elektronik Erişim <a href="https://doi.org/10.1007/978-981-19-9002-1">https://doi.org/10.1007/978-981-19-9002-1</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Data Monitoring Committees (DMCs) Past, Present, and Futureent://SD_ILS/0/SD_ILS:5278312026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Rawat, Nand Kishore. editor. Kerr, David. editor. SpringerLink (Online service)<br/>Yer Numarası ONLINE<br/>Elektronik Erişim <a href="https://doi.org/10.1007/978-3-031-28760-2">https://doi.org/10.1007/978-3-031-28760-2</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Handbook of Bioethical Decisions. Volume I Decisions at the Benchent://SD_ILS/0/SD_ILS:5278542026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Valdés, Erick. editor. Lecaros, Juan Alberto. editor. SpringerLink (Online service)<br/>Yer Numarası ONLINE<br/>Elektronik Erişim <a href="https://doi.org/10.1007/978-3-031-29451-8">https://doi.org/10.1007/978-3-031-29451-8</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Genome editing in drug discoveryent://SD_ILS/0/SD_ILS:5968662026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Maresca, Marcello, editor. Deswal, Sumit, editor.<br/>Yer Numarası RM301.25 .G46 2022<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9781119671404">https://onlinelibrary.wiley.com/doi/book/10.1002/9781119671404</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Principles of biomedical sciences and industry : translating ideas into treatmentsent://SD_ILS/0/SD_ILS:5977262026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Hinder, Markus, editor. Schuhmacher, Alexander, editor. Goldhahn, Jörg, editor. Härtl, Dominik, 1978- editor.<br/>Yer Numarası RM301.25<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9783527824014">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527824014</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Analytical scientists in pharmaceutical product development : task management and practical knowledgeent://SD_ILS/0/SD_ILS:5960472026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Xiao, Kangping, author.<br/>Yer Numarası RM301.25 .X53 2021<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9781119547785">https://onlinelibrary.wiley.com/doi/book/10.1002/9781119547785</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Characterization of pharmaceutical nano- and microsystemsent://SD_ILS/0/SD_ILS:5961672026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Peltonen, Leena Johanna, 1970- editor.<br/>Yer Numarası RS192<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9781119414018">https://onlinelibrary.wiley.com/doi/book/10.1002/9781119414018</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Innovative dosage forms : design and development at early stageent://SD_ILS/0/SD_ILS:5955922026-02-28T12:23:19Z2026-02-28T12:23:19ZYer Numarası RM301.25<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9783527812172">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527812172</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Biomarkers in drug discovery and development : a handbook of practice, application, and strategyent://SD_ILS/0/SD_ILS:5960002026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Rahbari, Ramin, 1965- editor. Van Niewaal, Jonathan, 1979- editor. Bleavins, Michael R., editor.<br/>Yer Numarası RM301.25 .B56 2020 EB<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9781119187547">https://onlinelibrary.wiley.com/doi/book/10.1002/9781119187547</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Early drug development : bringing a preclinical candidate to the clinic. Volume 1-2ent://SD_ILS/0/SD_ILS:5945852026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Giordanetto, Fabrizio, editor.<br/>Yer Numarası RM301.27 .E27 2018<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9783527801756">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527801756</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Pharmaceutical nanotechnology : innovation and productionent://SD_ILS/0/SD_ILS:5931972026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Voorde, M. H. van de (Marcel H.), editor. Cornier, Jean, editor. Kwade, Arno, editor. Owen, Andrew, editor.<br/>Yer Numarası RM301.25<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9783527800681">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527800681</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Controversial statistical issues in clinical trialsent://SD_ILS/0/SD_ILS:5475542026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Chow, Shein-Chung, 1955, author.<br/>Yer Numarası RM301.27 .C475 2011<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781439849620">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>Preclinical drug developmentent://SD_ILS/0/SD_ILS:5430282026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Rogge, Mark C. Taft, David R.<br/>Yer Numarası RM301.25 .P745 2010<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781420084733">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>Active pharmaceutical ingredients : development, manufacturing, and regulationent://SD_ILS/0/SD_ILS:5401132026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Nusim, Stanley.<br/>Yer Numarası RM301.25 .A28 2010<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781439803394">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>Biochips as pathways to drug discoveryent://SD_ILS/0/SD_ILS:5388322026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Carmen, Andrew. Hardiman, Gary, 1966-<br/>Yer Numarası R857 .B5 B54 2007<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781420015607">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>In vivo MR techniques in drug discovery and developmentent://SD_ILS/0/SD_ILS:5398912026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Beckmann, Nicolau.<br/>Yer Numarası RM301.25 .I5 2006<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781420004526">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>Dose Optimization in Drug Developmentent://SD_ILS/0/SD_ILS:5469742026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Krishna, Rajesh, editor. Taylor and Francis.<br/>Yer Numarası RM301.8 .D67 2006<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9780429136016">Click here to view.</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Preclinical Drug Developmentent://SD_ILS/0/SD_ILS:5401032026-02-28T12:23:19Z2026-02-28T12:23:19ZYazar Rogge, Mark C., editor. Taft, David R., editor. Taylor and Francis.<br/>Yer Numarası RM301.25 .P745 2005<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9780429163210">Click here to view.</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>